Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA
Background Immune-related adverse events (irAEs) are a serious side effect of immune checkpoint inhibitor (ICI) therapy for patients with advanced cancer. Currently, predisposing risk factors are undefined but understanding which patients are at increased risk for irAEs severe enough to require hosp...
Guardado en:
Autores principales: | Kun-Hsing Yu, Shannon Wongvibulsin, William Murphy, Leyre Zubiri, Vartan Pahalyants, Mark Kalinich, Feicheng Wang, Vivek Naranbhai, Alexander Gusev, Chenyue Lu, Shawn G Kwatra, Yevgeniy R Semenov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4140872710d449cbfe5498337fb0343 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Case study data for joint modeling of insurance claims and lapsation
por: Montserrat Guillen, et al.
Publicado: (2021) -
Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types
por: Feicheng Wang, et al.
Publicado: (2021) -
Development of algorithms for identifying patients with Crohn's disease in the Japanese health insurance claims database.
por: Hiromu Morikubo, et al.
Publicado: (2021) -
Decomposition of outpatient health care spending by disease - a novel approach using insurance claims data
por: Michael Stucki, et al.
Publicado: (2021) -
Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis
por: Kiss S, et al.
Publicado: (2018)